MPN News and Updates From ASCO 2017

: 0 Comments

As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center provides a hopeful update for patients living with myeloproliferative neoplasms (MPNs). Dr. Verstovsek shares news on JAK inhibitors in development, the hope of immune checkpoint inhibitors and other antibody treatments, as well as promising therapies in development for chronic anemia.  Tune in to learn more.

Sign in or Register to view comments.